A Pharmacist's view on biosimilars
Is denosumab superior to zoledronic acid in the treatment of bone metastases in MM?
What is HOPA doing for pharmacists and cancer patients
Susannah Koontz Webb
Advances in multiple myeloma: a collaborative effort
Immunotherapy highlights from ICML 2017